LMR Partners’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 822 |
|
|
2024
Q1 | – | Sell |
-25,000
| Closed | -$281K | – | 731 |
|
|
2023
Q4 | $281K | Sell |
25,000
-19,508
| -44% | -$219K | ﹤0.01% | 401 |
|
|
2023
Q3 | $116K | Buy |
+44,508
| New | +$116K | ﹤0.01% | 471 |
|
|
2023
Q2 | – | Sell |
-76,976
| Closed | -$325K | – | 766 |
|
|
2023
Q1 | $325K | Buy |
+76,976
| New | +$325K | 0.01% | 769 |
|
|
2022
Q4 | – | Sell |
-14,139
| Closed | -$181K | – | 1088 |
|
|
2022
Q3 | $181K | Hold |
14,139
| – | – | ﹤0.01% | 1009 |
|
|
2022
Q2 | $165K | Buy |
+14,139
| New | +$165K | ﹤0.01% | 1069 |
|
|
2022
Q1 | – | Sell |
-20,000
| Closed | -$183K | – | 1203 |
|
|
2021
Q4 | $183K | Sell |
20,000
-20,249
| -50% | -$185K | ﹤0.01% | 1074 |
|
|
2021
Q3 | $455K | Buy |
+40,249
| New | +$455K | 0.01% | 813 |
|
|
2021
Q2 | – | Sell |
-21,318
| Closed | -$301K | – | 1098 |
|
|
2021
Q1 | $301K | Buy |
+21,318
| New | +$301K | 0.01% | 734 |
|
|
2017
Q3 | – | Sell |
-804
| Closed | -$77K | – | 321 |
|
|
2017
Q2 | $77K | Buy |
+804
| New | +$77K | ﹤0.01% | 573 |
|